TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Gilead Sciences Sweden AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
43,564
|
31,556
|
32,349 |
| Financial expenses |
0
|
30
|
95 |
| Earnings before taxes |
2,082
|
1,104
|
1,037 |
| EBITDA |
1,925
|
1,188
|
1,188 |
| Total assets |
49,840
|
45,917
|
46,684 |
| Current assets |
49,304
|
45,335
|
45,993 |
| Current liabilities |
10,156
|
8,117
|
8,479 |
| Equity capital |
16,293
|
14,723
|
15,121 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
58
|
54
|
50 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.7%
|
32.1%
|
32.4% |
| Turnover per employee |
751
|
584
|
647 |
| Profit as a percentage of turnover |
4.8%
|
3.5%
|
3.2% |
| Return on assets (ROA) |
4.2%
|
2.5%
|
2.4% |
| Current ratio |
485.5%
|
558.5%
|
542.4% |
| Return on equity (ROE) |
12.8%
|
7.5%
|
6.9% |
| Change turnover |
11,917
|
1,827
|
-3,168 |
| Change turnover % |
38%
|
6%
|
-9% |
| Chg. No. of employees |
4
|
4
|
-3 |
| Chg. No. of employees % |
7%
|
8%
|
-6% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.